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Abstract
GWAS has facilitated greatly the discovery of risk SNPs associated with complex diseases. Traditional methods analyze SNP
individually and are limited by low power and reproducibility since correction for multiple comparisons is necessary. Several
methods have been proposed based on grouping SNPs into SNP sets using biological knowledge and/or genomic features.
In this article, we compare the linear kernel machine based test (LKM) and principal components analysis based approach
(PCA) using simulated datasets under the scenarios of 0 to 3 causal SNPs, as well as simple and complex linkage
disequilibrium (LD) structures of the simulated regions. Our simulation study demonstrates that both LKM and PCA can
control the type I error at the significance level of 0.05. If the causal SNP is in strong LD with the genotyped SNPs, both the
PCA with a small number of principal components (PCs) and the LKM with kernel of linear or identical-by-state function are
valid tests. However, if the LD structure is complex, such as several LD blocks in the SNP set, or when the causal SNP is not in
the LD block in which most of the genotyped SNPs reside, more PCs should be included to capture the information of the
causal SNP. Simulation studies also demonstrate the ability of LKM and PCA to combine information from multiple causal
SNPs and to provide increased power over individual SNP analysis. We also apply LKM and PCA to analyze two SNP sets
extracted from an actual GWAS dataset on non-small cell lung cancer.
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Introduction
Rapid progress in high throughput genotyping technology has
facilitated greatly the discovery of risk single-nucleotide polymor-
phisms (SNPs) associated with complex disease [1,2]. At present,
the population-based case control study is one of the most
commonly used designs in genome-wide association studies
(GWAS), with millions of SNPs being genotyped simultaneously
from more than one thousand cases and controls. A standard
approach to analyze GWAS data is to regress the phenotype on
each genotyped SNP. However, due to the large number of SNPs,
correction for multiple comparisons is necessary. As an example,
for a GWAS with 1M SNPs, each SNP should be tested at the level
of 5e-8 to maintain the overall a level at 0.05 [3], which may be
too stringent to reach.
It is possible that joint tests of multiple SNPs in linkage
disequilibrium (LD) are more powerful than testing each SNP
individually. There are several reasons for the superiority. Firstly,
the number of tests is reduced if SNPs are tested by group rather
than individually. Secondly, as the true causal SNP may not be
genotyped directly, combining the information from multiple
genotyped SNPs in LD with the causal SNP may be more effective
than testing each SNP individually [4]. Meanwhile, a joint test can
also examine whether a batch of biologically important SNPs are
associated with the phenotype.
Several SNP set analysis methods have been proposed. The
simplest way to determine the p-value of a SNP set is the
individual SNP analysis. This method uses the smallest p-value
of all SNPs, corrected for the number of effective tests, as the p-
value for the entire SNP set [3]. The number of effective tests
can be determined based on an upper bound for the overall
type I error probability and pairwise correlations among SNPs.
However, this method may not be optimal as it does not make
full use of the LD structure among the genotyped SNPs.
Gauderman et al. proposed a principal components analysis
based approach (PCA), by which principal components (PCs)
are computed from the SNP set and included in the regression
model to test for the association [5]. Wu et al. proposed a
powerful logistic kernel machine based test (LKM) to examine
the association between the disease outcome and a SNP set [6].
Their simulations indicated that LKM has greater power than
individual SNP analysis. On the basis of LKM, Wu et al.
further proposed the sequence kernel association test (SKAT)
which can test for the association between common or rare
genetic variations in a region and a disease outcome [7].
In this article, we compare the performance of LKM and PCA
by using simulated datasets. The structure of this article is as
follows. The procedures of LKM and PCA will be briefly
described. Results of several simulation studies are provided to
compare test power and type I error rate between the two
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.  Prinicpal  Component  Analysismethods. We then demonstrate the application of these two
methods to two SNP sets extracted from a Lung Cancer GWAS
dataset, and finally discuss the implications of our results.
Methods
For a SNP set includes p SNPs from n individuals, let
zi~ zi1,zi2,...,zip
   T denote the ith individual’s genotypes. The
disease outcome is denoted by D(1=affected, 0=unaffected).
Logistic Kernel Machine Based Test
For the ith individual, LKM takes the form of
logitPD i~1 ðÞ ~a0za1xi1za2xi2z   zamximzh zi ðÞ
In the above equation, a0 is the intercept, xi1, xi2,…, xim denote
m covariates to be adjusted for and a1 …, am are their coefficients.
The association between the SNP set and the outcome is modeled
by a function h(.), which is defined by h zi ðÞ ~
Xn
i0~1 ciK zi,zi0 ðÞ for
some c1, c2,…, cn. K(.,.) is a kernel function which measures the
similarity between zi and zi’. Some choices for K(.,.) include the
linear, identical-by-state (IBS), weighted linear and weighted IBS
[6]. The linear kernel, K zi,zi0 ðÞ ~
Xp
j~1 zijzi0j, is the usual inner
product between the vectors from 2 subjects. The IBS kernel
measures the distance between individuals on the basis of the
number of alleles shared identical by state (IBS) by a pair. Wu et
al. suggested the use of the linear kernel if no epistatic effects are
expected and the IBS otherwise. The weighted kernels impose
weights to SNPs based on their allele frequencies or biological
information.
Liu et al. described the connection between LKM and
generalized linear mixed model (GLMM) [8]. They showed that
h(.) could be regarded as a subject-specific random effect with a
mean of zero and a variance of tK. Thus a score test on t=0
could be used to test the null hypothesis of no association.
Principal Component Analysis Based Analysis
We first standardize each of the genotype by re-scaling it to have
a mean of 0 and a standard deviation of 1. The variance-
covariance matrix of the standardized SNP set is denoted as Vp6p.
Let Ep|p~ e1,e2,...,ep
  
denote the pp -dimension eigenvectors
of Vp6p, and Lp~ l1,l2,...,lp
  
denotes the p corresponding
eigenvalues, in which l1.l2.…. lp. For the ith individual, the
principal components are
PCi1~eT
1zi~e11zi1ze12zi2z   ze1pzip
PCi2~eT
2zi~e21zi1ze22zi2z   ze2pzip
. .
.
PCip~eT
pzi~ep1zi1zep2zi2z   zeppzip
By definition, el is selected to maximize the variance of PCl with
the constraint that el
Tel~1. The covariance between PCl and PCl’
is zero for l?l’. ll measures the variation explained by PCl.A s
SNPs in the set are always highly correlated with each other, the
first few eigenvalues will be much greater than the others. This
makes it possible to use the first few PCs to capture most of the
variation in the SNP set. To do this, we only need to select the first
k PCs with cumulative contribution
Xk
l~1 ll
.Xp
l~1 ll greater
than some threshold (eg. 80%). Instead of using the p SNPs, we will
use the first k PCs in the multiple logistic model by:
logitPD i~1 ðÞ ~a0za1xi1za2xi2z   zamximz
Pk
l~1 dlPCil
A k-df likelihood ratio test can be used to test the significance of
the SNP set. For simplicity, we will use PCA(Z%) to denote the
PCA with the PCs explaining at least Z% of the total variation. As
example, if the top 2, 3 and 4 PCs explain 63%, 75% and 80% of
Table 1. Parameter settings of all simulations.
the simulated SNP Set Scenario Number of causal SNPs Locations of the causal SNPs Designed RR
CLPTM1L(31 SNPs) A1 0 – 1.0
5p13.33 A2 1 1 of 31 in turn 1.1
A3 1 1 of 31 in turn 1.2
A4 2 15 and 22 1.1
A5 2 11 and 22 1.1
A6 2 7 and 14 1.1
A7 2 11 and 30 1.1
A8 2 6 and 29 1.1
A9 2 11 and 26 1.1
A10 2 11 and 29 1.1
A11 3 All three-SNP combinations of
6,7,11,14,15,22,26,29,30
1.1
ASAH1 (154 SNPs) B1 0 – 1.0
8p22 B2 1 1 of 154 in turn 1.2
B3 2 26 and 81 1.1
B4 2 81 and 126 1.1
doi:10.1371/journal.pone.0044978.t001
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and PCA(80%) are 2, 3 and 4, respectively.
Simulations
We use simulated datasets to evaluate the performances of
LKM and PCA. Measurements for comparison include empirical
type I error rate and test power. All the causal SNPs are assumed
to improve the risk. We assume the disease model is
logitPD i~1 ðÞ ~a0z
PC
j~1 bjzij
Here, C is the number of causal SNPs, bj is the log genetic
relative risk (RR) of the jth causal SNP. We use a log-additive
inheritance model in our simulation by imposing the assumption
that risk multiplies with each additional allele. We let C=0 to 3 in
our simulations, denoting null, single causal SNP, two or three
causal SNPs model.
Simulations based on the CLPTM1L gene. Datasets are
simulated on the basis of the CLPTM1L gene, a 27.35kb-long-gene
located at 5p13.33. It encodes cleft lip and palate trans-membrane
protein 1-like protein. Two SNPs in this gene, rs31489 and
rs401681, were reported to be associated with non-small cell lung
cancer (NSCLC) [9,10]. We download the phased haplotypes of
CEU (CEPH [Utah residents with ancestry from northern and
western Europe]) samples from the website of the International
HapMap Project (Phase 2, release 22). Thirty one SNPs, located
within the range of 20kb upstream and downstream of the
CLPTM1L gene, are used as the template of the simulated
sequence. We use HAPGEN (version 2) to generate the simulated
datasets [11,12].
We conduct 11 scenarios of simulations based on the CLPTM1L
gene (scenarios A1–A11). Parameters of the simulations are
described by Table 1. Scenario A1 is simulated to evaluate the
performances of the two methods on controlling type I error. We
generate 1,000 cases and 1,000 controls under the null disease
model (C=0), in which the outcome is independent of the loci.
The empirical type I error rate is calculated as the proportion of
rejecting the null hypothesis in the 5,000 simulated datasets.
Scenarios A2 and A3 are simulated to compare the powers of
LKM and PCA when there is only one causal SNP in the region.
We set the genetic RR as 1.1 and 1.2 at scenarios A2 and A3,
respectively. In both scenarios, each of the 31 SNPs in the
CLPTM1L gene is set to be the causal SNP in turn. For each causal
SNP, 1,000 datasets are simulated. The test power is calculated as
the proportion of p-values less than 0.05. To make the simulations
more realistic, only 8 of the 31 SNPs are used by LKM and PCA,
which are directly genotyped by the Illumina 610k Quad chip.
We also examine the ability of these methods on utilizing
information from multiple loci assuming that there are 2 or 3
causal SNPs with RR=1.1 (scenarios A4 to A11). Both of the two
causal SNPs are genotyped in scenario A4. In scenarios A5–A8,
only one of the two causal SNPs is genotyped. No causal SNPs are
genotyped in scenarios A9 and A10. Besides the number of
genotyped causal SNPs, the difference among scenarios A4–A10 is
reflected by the different median R
2 between the causal SNP and
the genotyped SNPs. Details of these scenarios are presented in the
first 6 columns of Table 2. In scenario A11, we assume that there
are 3 causal SNPs. For each of the three-SNP combinations (84 in
total) from the 9 causal SNPs used in scenarios A4–A10 (Table 1),
1,000 datasets are simulated.
Simulations based on the ASAH1 gene. ASAH1, acid
ceramidase 1, is a 28.5-kb-long gene located at 8p22. It was
reported to be associated with prostate cancer and Farber disease
[13,14]. The reference haplotype downloaded from HapMap
includes 154 SNPs, with a more complex LD structure than the
CLPTM1L gene. Four scenarios are simulated, in which scenario
B1 evaluates the type I error and B2 to B4 evaluate the test power.
In scenario B1, 5,000 datasets are simulated with no association
between the disease outcome and the SNPs. In scenario B2, each
of the 154 SNPs is set to be the causal SNP with a RR of 1.2 in
turn. There are 1,000 simulated replicates for each of the causal
SNP. Again, although the simulated datasets are generated using
the overall 154 SNPs, only 39 genotyped SNPs are used in the
analyses. Scenarios B3 and B4 both assume 2 causal SNPs with
RR=1.1. Both of the two causal SNPs are in strong LD with the
genotyped loci in B3, while one causal SNP is in weak LD with the
genotyped loci in B4. The causal SNPs in scenarios B3 and B4 are
all common SNPs (MAF<40%). The aim of these two scenarios is
to evaluate the performance of LKM and PCA when causal SNPs
are in the same or different LD blocks in a relatively large SNP set.
Application of LKM and PCA to two SNP Sets from a
GWAS Dataset
We apply the two methods to test the significance of 2
regions extracted from a GWAS dataset studying the genetic
susceptibility of non-small cell lung cancer (NSCLC). Details of
participant recruitment for the study have been described
previously [15]. This dataset includes 984 NSCLC cases and
970 controls recruited from Massachusetts General Hospital.
DNA was extracted from the whole blood and genotyped using
the Illumina 610k Quad chip. A total of 543,697 SNPs pass the
general quality control (QC) procedure [16]. The first region
Table 3. Empirical type I error rates at the significant level of 0.05 for LKM and PCA.
LKM PCA
Scenario gene a Individual SNP Analysis Linear IBS Linear weighted IBS weighted 80% 60% 40% 20%
A1 CLPTM1L 0.05 0.029 0.050 0.048 0.052 0.051 0.050 0.051 0.050 0.050
0.01 0.005 0.011 0.010 0.012 0.011 0.010 0.010 0.009 0.009
0.001 0.000 0.000 0.001 0.001 0.001 0.001 0.001 0.001 0.001
B1 ASAH1 0.05 0.026 0.051 0.050 0.044 0.049 0.056 0.054 0.050 0.051
0.01 0.006 0.010 0.011 0.008 0.010 0.012 0.011 0.011 0.009
0.001 0.000 0.002 0.002 0.001 0.001 0.001 0.002 0.002 0.002
The type-I error rates significantly different from the nominal type-I error level are highlighted by using italics font.
doi:10.1371/journal.pone.0044978.t003
Association Test Based on SNP Set
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CLPTM1L gene. The second one is an 116kb region, which
includes 21 SNPs in 15q24-25. Genes in this region include the
CHRNA3, CHRNA5 and CHRNB4. These 3 genes were reported
to be associated with nicotine addiction, smoking behavior and
NSCLC [17–19]. Covariates adjusted in the analysis include
age, gender(male/female) and smoking status (never/ever). The
top 4 axes of variation generated by the EIGENSTRAT
analysis are also included in the models to control for the
confounding effect of population stratification [20,21].
R package (version 2.13) is used to analyze both of the simulated
and actual datasets. The SKAT package (version 0.73) is used to
conduct LKM analysis. For the weighted kernel functions, we use
the default weight of
ﬃﬃﬃﬃ
w
p
~Beta MAF;a1,a2 ðÞ , in which MAF is
the SNP’s minor allele frequency, a1=1 and a2=25, Beta() is the
density function of a b distribution. We also perform individual
Figure 1. Power, the causal SNP and the genotyped SNPs in scenarios A2 and A3 based on the CLPTM1L gene. The top 2 plots show the
power (y-axis) of each method over the locations (x-axis) of the causal SNPs. The triangles in the plot are the locations of the genotyped SNPs. The
bar-plot shows the MAFs of all SNPs. The LD structure of the 31 SNPs is shown by the heat plot in the bottom of the figure, in which the gray scale
indicates the value of R
2 (1=black, 0=white).
doi:10.1371/journal.pone.0044978.g001
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set, a logistic regression model is fitted for each locus. The p-value
of the set is then determined by the minimum p-value of all the
loci, corrected by the effective number of tests [3].
Results
Empirical Type I Error Rate
The empirical type I error rate of LKM, PCA and individual
SNP analysis are presented by Table 3. Both LKM and PCA
control the type I error at the significant level of 0.05, 0.01 or
0.001. For the CLPTM1L gene, the mean numbers of PCs to
explain at least 80%, 60%, 40% and 20% of the total variation are
3.00, 2.00, 1.00 and 1.00, respectively. For the ASAH1 gene, the
corresponding mean numbers of PCs are 6.85, 3.06, 1.92 and
1.00, respectively. The result indicates that type I error rate is
independent of the number of PCs included in the model. The
individual SNP analysis is conservative in both scenarios. Table S1
gives the standard errors of the type I error rate estimates.
Empirical Test Power Based on the CLPTM1L Gene with
Single Causal SNP
Results from scenarios A2 and A3 are presented by Figure 1. In
general, both of LKM and PCA have power when the causal SNP
is in high LD with the genotyped ones, which demonstrates their
ability of ‘‘borrowing’’ information to increase the statistical
power. Among the 4 LKM models, the one with linear kernel has
the greatest power in most occasions. For PCA, we present the
powers of PCA using PCs explaining at least 80%, 60% and 40%
of the total variation, respectively. As the CLPTM1L gene is a small
gene with a simple LD structure, only a very small number of PCs
are needed to explain a large proportion (.40%) of the total
Figure 2. The relationship between the test power and the median R
2 between the causal SNP and the genotyped SNPs in scenarios
A2, A3 and B2. The causal SNP on the x-axis has been ordered by the median R
2 in ascending. The test power of each causal SNP is plotted on the
order of median R
2 between the corresponding SNP and the genotyped ones. The 2 bar plots in the figure represent the MAFs of SNPs in the
CLPTM1L and ASAH1 genes, respectively.
doi:10.1371/journal.pone.0044978.g002
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exactly the same. PCA(40%) is more powerful than the other
PCAs when the causal SNP is at one of the 5
th,6
th,1 0
th–13
th and
15
th–28
th loci, as shown in Figure 1. Its power is very close to, or
even greater than that of the LKM with linear kernel at some loci.
This may due to the fact that when PCs in the model have already
explained the difference between cases and controls, including
more PCs will not improve the model, but instead exhaust more
degrees of freedom and decrease the test power. However, if the
causal SNP is in linkage equilibrium (LE) or is in weak LD with the
genotyped SNPs, or located in a small LD block other than the
one in which most of the genotyped SNPs reside in, including
more PCs will improve the test power. This is confirmed by the
causal SNP at one of the 1
st–4
th and 29
th–31
st loci, where
PCA(80%) is dominant than LKM and the other PCAs. It is worth
noting that although LKMs with linear or IBS weighted kernel do
not have good performance in general, they are more powerful
than the others when the MAF of the causal SNP is low (the 7
th,
8
th or 14
th SNP in Figure 1).
The top 2 panels in Figure 2 illustrate the relationship between
the test power and the LD between the causal SNP and the
genotyped SNPs. As we expected, the test power for either of
LKM and PCA increases as a function of the median R
2.A s
displayed in the left portion of this plot where the causal SNP is in
LE or weak LD with the genotyped SNPs, PCA(80%) is more
powerful than LKM and the other PCAs since more PCs are
needed to ‘‘capture’’ the information that differentiates cases and
controls. This is true except when the causal SNPs have low
MAFs. It is not surprising that PCA(40%) and LKM with linear
kernel have better performance than the others, shown at the right
part of these 2 plots.
When compared to the individual SNP analysis, PCA and LKM
are more powerful in most situations. However, when the causal
SNP is in the 2
nd,2 9
th or 30
th locus with a RR of 1.2, the
individual SNP analysis has greater power than the others. We
believe this is not surprising because the inclusion of un-associated
SNPs may ‘‘dilute’’ the effect of the causal.
Figure 3. Power, the causal SNP and the genotyped SNPs in scenario B2 based on the ASAH1 gene. The top plot shows the power (y-axis)
of each method over the locations (x-axis) of the causal SNPs. The triangles in the plot are the locations of the genotyped SNPs. The bar-plot in the
middle shows the MAFs of all SNPs. The bottom plot shows the LD structure of the 154 SNPs downloaded from the HapMap project.
doi:10.1371/journal.pone.0044978.g003
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Results of scenario B2 are shown by Figure 3. Because the LD
structure of the ASAH1 gene is more complex than that of the
CLPTM1L gene, we also show the results from PCA(20%). The
LD plot at the bottom of Figure 3 indicates that there are two LD
blocks in the SNP set (the 1
st to the 119
th and the 120
th to the
154
th). In the first block, the power from LKM with linear kernel
and PCA(20%) is dominant than the others. Whereas in the
second block, it is interesting to find that the power from
PCA(60%) < PCA(40%).PCA(80%).PCA(20%). PCA(60%)
and PCA(40%) are also more powerful than LKMs. The influence
of MAF, LD structure and number of PCs in the model on test
power is also demonstrated by the bottom panel of Figure 2.
Empirical Test Power Based on Genes with More than
One Causal SNP
Results from scenarios A4 to A11 are presented by Tables 2 and
S2. Once again, test power is affected by the strength of LD
between the causal and genotyped SNPs. When both of the two
causal SNPs are in strong LD with the genotyped ones (scenarios
A4, A5 and A9), the power from LKM with linear or IBS kernel,
as well as PCA(40%), is over 80%. The test power is dramatically
reduced when at least one of the causal SNPs is in weak LD with
the genotyped SNPs (scenarios A6–A8 and A10). When both of
the causal SNPs are in weak LD with the genotyped SNPs
(scenarios A6), PCA(80%) and PCA(60%) are more powerful than
the other PCAs as a large number of PCs are necessary to capture
the causal SNPs. For scenario A7, the powers generated from the 3
PCAs are very similar. Although PCA(80%) exhausts more
degrees of freedom than PCA(40%), it may capture the
information from the second causal SNP as a compensation by
including more PCs. Due to the low MAFs, LKMs with weighted
kernel functions are more superior to the other methods in
scenario A6. The comparison of results from scenarios A4–A10 to
those from A2, in which RR is also 1.1, demonstrates the
advantage of LKM and PCA on combining information from
several SNPs. Simulations based on the ASAH1 gene from
scenarios B3 and B4 generate similar results (Tables 4 and S3).
Scenario A11 in which there are 3 causal SNPs in the
CLPTM1L gene yields similar conclusion that tests combing
multiple SNPs tend to have higher power and the power increases
with the strength of LD between causal and genotyped SNPs
(Figure S1).
Application on Harvard Lung Cancer GWAS
The results of the analysis are shown in Table 5. For SNP set 1,
rs31489 from the CLPTM1L gene yields the least p-value of 1.96E-
6 (1.23E-5 after the Bonferroni correction for the effective number
of tests). The p-value of the LKM with linear kernel is 3.16E-6, the
least of all LKMs. The least p-value of PCA (6.83E-6) happens
when the PCs in the model explain 20% or 40% of the total
variation. For SNP set 2, PCA (60%) is dominant than the other
methods. LKMs with weighted kernels are less powerful than the
other methods due to the fact that the possible associated SNPs are
common ones (rs31489:38.56%; rs1051730:39.64%).
To understand how PCA utilizes the information from multiple
SNPs, we also examine the coefficient of each SNP in the top PCs.
For each SNP set, we regress the disease outcome on the top PCs.
The 1
st PC from SNP set 1 and the 2
nd PC from SNP set 2, which
are significant, are then presented by Figure 4. The significant PCs
tend to have heavy loading on the ‘‘important’’ SNPs. As an
example, for SNP set 1, the 1
st PC has heavy loadings on rs31489
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value=5.80E-6).
Discussion
In this article, we compare the performance of logistic kernel
machine based test and principal component analysis based test
for the analysis of GWAS. Both of these two methods have the
ability to test the association between a continuous or discrete
outcome and a set of SNPs grouped by biological knowledge or
genomic characteristics. We conduct extensive simulation studies
using datasets generated based on the haplotypes downloaded
from the International HapMap Project. We also apply these two
methods to two SNP sets extracted from a GWAS data on
NSCLC. The results demonstrate that both methods can correctly
control the type I error. If the causal SNP(s) is/are in strong LD
with the genotyped SNPs, both methods are superior to individual
SNP analysis due to the ability of borrowing information from the
genotyped SNPs in LD with the causal SNP(s). Furthermore, if
there are two or more causal SNPs in a SNP set, LKM and PCA
can combine their information and provide higher test power than
individual SNP analysis.
Linear kernel performs well in most occasions in our simulation
studies. Although slightly inferior to linear kernel, IBS kernel is
claimed to have better performance when there is epistatic effect in
the SNP set [6]. LKMs with weighted kernels are superior if the
causal SNP has low MAF, as demonstrated by the results from
scenario A6 (in which both causal SNPs have MAF ,20%, as well
as causal SNPs with low MAFs in scenarios A2 and A3 (the 7
th,8
th
and 14
th SNPs).Thus LKM with weighted kernel may be a good
choice when there is evidence that the MAF of the causal SNP is
low. Meanwhile, when analyzing the same SNP set, if the weighted
LKM generates a positive result while the un-weighted LKM does
not, it is possible that the causal SNP in the region may have low
MAF. Recent studies also indicate LKMs with weighted kernels
has good performance when the disease is associated with rare
variations [7]. The SKAT package in R also provides flexible
weight specification options, which makes it possible to detect the
association between disease and rare variations by giving the
variations appropriate weights. This makes LKM a powerful and
flexible tool in the coming age of next generation sequencing.
Test power from PCA is affected by the number of PCs
included in the analysis. Simulation indicates that if the number of
PCs is correctly specified, PCA may have even better performance
Table 5. Results of LKM and PCA on the Analysis of the SNP sets from the Harvard Lung Cancer Susceptibility Study.
SNP
set Individual SNP Analysis LKM PCA
The least p-value in the
SNP set
p-values for the
SNP set Linear IBS
Linear
weighted
IBS
weighted 80% 60% 40% 20%
1 1.96E-6 1.23E-5 3.16E-6 6.96E-6 4.70E-2 1.01E-2 3.67E-5 2.56E-5 6.83E-6 6.83E-6
2 5.61E-6 6.74E-5 3.07E-4 1.78E-4 3.15E-1 1.44E-1 3.48E-6 8.67E-7 9.31E-1 9.31E-1
doi:10.1371/journal.pone.0044978.t005
Figure 4. Loadings of the significant PCs on each of the SNP in the SNP sets from 5p13.33 and 15q24-25. The diameters of the circles in
the plots are proportional to –log10(p-value).
doi:10.1371/journal.pone.0044978.g004
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PCA may not be an easy task. In our simulation, we use PCA with
different numbers of PCs to analyze SNP sets with simple or
complex LD structure. For the simulation based on the CLPTM1L
gene, if the causal SNP resides in the region in high LD with most
of the genotyped SNPs, only the 1
st PC is needed to capture the
information of the causal SNP. Including more PCs will decrease
the power. While in the simulation based on the ASAH1 gene,
more PCs should be included in the model to increase the power if
the causal SNP resides in the right side of the SNP set (as shown in
the second LD block in Figure 3), in which only about 1/3 of the
genotyped SNPs reside.
Thus it is critical to examine the LD structure of the SNP set
before performing a LKM or PCA analysis. We suggest the SNP
set to include SNPs in a LD block. In this situation, LKM and
PCA with only a few top PCs may have good performance.
However, if the SNP set covers a wide region containing several
LD blocks, we suggest using PCA with PCs explaining a large
proportion of variation to capture the information of the causal
SNP(s). Chen et al. proposed a supervised PCA procedure for
pathway-based analysis, in which only SNPs mostly associated
with the disease outcome are used to extract PCs [22]. They used
an approximate sampling distribution of the test statistics with a
simulation-based standardization procedure to correct for the
effect of pathway size. However, they used only the 1
st PC in the
analysis, which has the risk of missing the causal SNP(s) if the LD
structure of the SNP set is complex. A possible way to improve the
power of PCA is to exclude the PCs independent of the causal
SNPs. Although we can perform a feature selection procedure on
PCs, such as only including significant PCs in the model, we risk
increasing the type I error rate as the feature-selection procedure is
ignored by the likelihood ratio test. A permutation procedure
could be used to build the sampling distribution of the test statistic
for the PCs after the feature-selection. However, this procedure is
not efficient as one may need thousands of permutation samples to
get a p-value small enough. More theoretical research should be
taken for a solution to build a corresponding asymptotic
distribution to improve the efficiency.
Both of LKM and PCA are capable of handling epistasis. PCA
can also easily handle gene-environmental interactions, while it is
still an issue for LKM. A possible limitation of PCA is the difficulty
in interpretation of the results. However, just like LKM, a
significant SNP set in PCA can be followed by a fine mapping or
deep sequencing to identify the true causal SNP as the causal one
should reside in the region in or close to the significant SNP set.
Meanwhile, by checking the loading of the significant PCs on each
SNP, we can identify which SNPs are more associated with the
disease. By combining LKM or PCA with a moving window
strategy, it is possible that we can have more precise information
on where the causal SNP resides.
We acknowledge that our study has several limitations. Firstly,
only LKM and PCA are evaluated, although there are several
other SNP set based methods. In the LKM’s original paper [6],
the comparison between LKM and other methods suggests that
LKM is a powerful method. On the basis of their study, we further
demonstrate that PCA, a traditional multivariate method, is
comparable on many perspectives to LKM. Secondly, more
complicated situations, such as rare variations and gene-gene
interaction, are not included in the study. Further investigations
are needed to address these issues.
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Figure S1 The relationship between the test power and
the median R
2 between the causal and the genotyped
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